Danske Bank A/S Moderna, Inc. Transaction History

Danske Bank A/S

  • $1.95 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025
BUY
$23.51 - $34.67 $143,058 - $210,966
6,085 New
6,085 $157,000
Q2 2025

Dec 18, 2025
SELL
$23.65 - $28.54 $2.85 Million - $3.45 Million
-120,714 Reduced 95.2%
6,085 $167,000
Q1 2025

Dec 18, 2025
BUY
$28.35 - $47.53 $3.42 Million - $5.74 Million
120,714 Added 1983.8%
126,799 $3.59 Million

Others Institutions Holding MRNA

# of Institutions
845
Shares Held
257M
Call Options Held
39.6M
Put Options Held
43.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email